LUNG Insider Trading Activity and SEC Form 4 Filings
LUNG insider trading summary
Over the past 12 months, insiders at Pulmonx Corp (LUNG) reported 55 sales worth $548K by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $548K.
Latest LUNG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Glendon E. French III | President and CEO | Sell | $9K (4,098 @ $2.26) |
| Sep 1, 2026 | David Aaron Lehman | General Counsel | Sell | $11K (4,827 @ $2.26) |
| Sep 1, 2026 | David Aaron Lehman | General Counsel | Sell | $9K (3,807 @ $2.26) |
| Sep 1, 2026 | Geoffrey Beran Rose | Chief Commercial Officer | Sell | $4K (1,746 @ $2.26) |
| Sep 1, 2026 | David Aaron Lehman | General Counsel | Sell | $5K (2,224 @ $2.26) |
| Sep 1, 2026 | David Aaron Lehman | General Counsel | Sell | $8K (3,476 @ $2.26) |
| Sep 1, 2026 | Geoffrey Beran Rose | Chief Commercial Officer | Sell | $5K (2,390 @ $2.26) |
| Sep 1, 2026 | Geoffrey Beran Rose | Chief Commercial Officer | Sell | $5K (2,213 @ $2.26) |
| Sep 1, 2026 | Geoffrey Beran Rose | Chief Commercial Officer | Sell | $3K (1,530 @ $2.26) |
| Sep 1, 2026 | Glendon E. French III | President and CEO | Sell | $85K (37,784 @ $2.26) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.